Evidence map›Paper›PMID 38824256›Full record

ArticleScientific reports2024

A multi-strategy improved rime optimization algorithm for three-dimensional USV path planning and global optimization.

Gaoquan Gu, Jingjun Lou, Haibo Wan

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gaoquan GuCollege of Naval Architecture and Ocean Engineering, Naval University of Engineering, Wuhan, 430033, Hubei, China.
Jingjun LouCollege of Naval Architecture and Ocean Engineering, Naval University of Engineering, Wuhan, 430033, Hubei, China. loujingjun760525@163.com.
Haibo WanCollege of Naval Architecture and Ocean Engineering, Naval University of Engineering, Wuhan, 430033, Hubei, China.

Funding

Equipment Development Department of the Central Military Commission 61400040502
6 · The paper itself

Abstract

The RIME optimization algorithm (RIME) represents an advanced optimization technique. However, it suffers from issues such as slow convergence speed and susceptibility to falling into local optima. In response to these shortcomings, we propose a multi-strategy enhanced version known as the multi-strategy improved RIME optimization algorithm (MIRIME). Firstly, the Tent chaotic map is utilized to initialize the population, laying the groundwork for global optimization. Secondly, we introduce an adaptive update strategy based on leadership and the dynamic centroid, facilitating the swarm's exploitation in a more favorable direction. To address the problem of population scarcity in later iterations, the lens imaging opposition-based learning control strategy is introduced to enhance population diversity and ensure convergence accuracy. The proposed centroid boundary control strategy not only limits the search boundaries of individuals but also effectively enhances the algorithm's search focus and efficiency. Finally, to demonstrate the performance of MIRIME, we employ CEC 2017 and CEC 2022 test suites to compare it with 11 popular algorithms across different dimensions, verifying its effectiveness. Additionally, to assess the method's practical feasibility, we apply MIRIME to solve the three-dimensional path planning problem for unmanned surface vehicles. Experimental results indicate that MIRIME outperforms other competing algorithms in terms of solution quality and stability, highlighting its superior application potential.

Indexed as

Metaheuristic algorithmNumerical optimizationRime optimization algorithmThree-dimensional USV path planning

Identifiers

PMID38824256
PMCPMC11144218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.